Evidence map›Paper›PMID 38987603›Full record

ArticleNature2024

CryoET of β-amyloid and tau within postmortem Alzheimer's disease brain.

Madeleine A G Gilbert, Nayab Fatima, Joshua Jenkins, Thomas J O'Sullivan, Andreas Schertel, Yehuda Halfon, Martin Wilkinson, Tjado H J Morrema, Mirjam Geibel, Randy J Read and 4 more

Abstract read
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  17. Article
  18. IR-AMES uncovers structure and composition of Alzheimer's tau oligomers.bioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Madeleine A G Gilbert *Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0009-0007-3609-7499
Nayab Fatima *Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Joshua Jenkins *Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Thomas J O'Sullivan *Astbury Biostructure Laboratory CryoEM facility, Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Andreas SchertelZEISS Microscopy Customer Center Europe, Carl Zeiss Microscopy GmbH, Oberkochen, Germany.
Yehuda HalfonAstbury Biostructure Laboratory CryoEM facility, Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Martin WilkinsonAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0001-5490-613X
Tjado H J MorremaDepartment of Pathology, Unit Neuropathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Mirjam GeibelZEISS Microscopy Customer Center Europe, Carl Zeiss Microscopy GmbH, Oberkochen, Germany.
Randy J ReadDepartment of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-8273-0047
Neil A RansonAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-3640-5275
Sheena E RadfordAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-3079-8039
Jeroen J M HoozemansAstbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-2888-8967
René A W FrankAstbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK. r.frank@leeds.ac.uk.ORCID 0000-0001-9724-9547

Funding

Medical Research Council MR/T011149/1Wellcome Trust 108466Wellcome Trust 204963/Z/16/ZWellcome Trust 208395Wellcome Trust 209407/Z/17/ZWellcome Trust 221524
6 · The paper itself

Abstract

A defining pathological feature of most neurodegenerative diseases is the assembly of proteins into amyloid that form disease-specific structures

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesBrainCryoelectron MicroscopyElectron Microscope TomographyPlaque, Amyloidtau ProteinsAmyloid beta-Protein PrecursorAnimalsAutopsyExtracellular VesiclesHumansMaleMiceAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAPP protein, humanMAPT protein, humantau Proteins

Identifiers

PMID38987603
PMCPMC11269202

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.